Total Payments
$4,656
2024 Payments
$710.43
Companies
35
Transactions
211
Medicare Patients
4,994
Medicare Billing
$628,380
Payment Breakdown by Category
Food & Beverage$4,612 (99.1%)
Education$43.98 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,612 | 209 | 99.1% |
| Education | $43.98 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,107 | 66 | $0 (2024) |
| Novo Nordisk Inc | $638.88 | 30 | $0 (2024) |
| ABBVIE INC. | $419.42 | 15 | $0 (2022) |
| Amgen Inc. | $282.57 | 3 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $266.04 | 12 | $0 (2023) |
| Medtronic MiniMed, Inc. | $210.57 | 5 | $0 (2020) |
| Abbott Laboratories | $202.55 | 6 | $0 (2022) |
| Echosens North America, Inc. | $159.60 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $131.96 | 7 | $0 (2024) |
| Medtronic, Inc. | $128.84 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $710.43 | 24 | Amgen Inc. ($263.97) |
| 2023 | $986.89 | 37 | Novo Nordisk Inc ($262.05) |
| 2022 | $959.04 | 45 | Lilly USA, LLC ($410.50) |
| 2021 | $494.37 | 31 | Lilly USA, LLC ($201.45) |
| 2020 | $197.89 | 11 | Lilly USA, LLC ($76.56) |
| 2019 | $546.02 | 26 | Medtronic MiniMed, Inc. ($155.86) |
| 2018 | $391.49 | 24 | Lilly USA, LLC ($60.03) |
| 2017 | $370.30 | 13 | AbbVie, Inc. ($253.06) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Durable Pump | ||||||
| 10/01/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Cardiology | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Obesity | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Endocrinology | ||||||
| 05/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $144.27 | General |
| Category: Cardiology | ||||||
| 04/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Obesity | ||||||
| 03/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Obesity | ||||||
| 01/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Diabetes | ||||||
| 01/08/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Diabetes | ||||||
| 01/03/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes | ||||||
| 12/19/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,234 | 2,219 | $361,285 | $184,105 |
| 2022 | 10 | 1,445 | 2,486 | $347,945 | $174,855 |
| 2021 | 9 | 1,311 | 2,282 | $316,425 | $168,018 |
| 2020 | 8 | 1,004 | 1,523 | $234,287 | $101,402 |
Total Patients
4,994
Total Services
8,510
Medicare Billing
$628,380
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 552 | 1,258 | $232,730 | $127,862 | 54.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 125 | 125 | $43,750 | $21,965 | 50.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 149 | 151 | $33,975 | $15,301 | 45.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 70 | 72 | $12,600 | $5,309 | 42.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 224 | 458 | $16,030 | $4,334 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,300 | $4,025 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 45 | $6,580 | $3,000 | 45.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 44 | 79 | $6,320 | $2,308 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 516 | 1,150 | $213,200 | $114,771 | 53.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 148 | 152 | $34,200 | $15,719 | 46.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 72 | 72 | $25,200 | $13,370 | 53.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 157 | 158 | $26,650 | $11,849 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $13,740 | $5,949 | 43.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 235 | 491 | $15,320 | $4,609 | 30.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 16 | 16 | $7,440 | $3,755 | 50.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 47 | $6,815 | $3,346 | 49.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 201 | 335 | $4,020 | $992.16 | 24.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 13 | 17 | $1,360 | $494.56 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 497 | 1,100 | $203,760 | $113,914 | 55.9% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 137 | 138 | $25,700 | $14,907 | 58.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 75 | 75 | $26,250 | $14,247 | 54.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 70 | 70 | $19,600 | $10,147 | 51.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 69 | $10,005 | $4,524 | 45.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 225 | 415 | $12,450 | $3,971 | 31.9% |
| 93925 | Ultrasound study of arteries and arterial grafts of both legs | Office | 2021 | 14 | 14 | $6,510 | $3,202 | 49.2% |
About Dr. Ali Safa, MD
Dr. Ali Safa, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Vienna, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952475048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Safa, MD has received a total of $4,656 in payments from pharmaceutical and medical device companies, with $710.43 received in 2024. These payments were reported across 211 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,612).
As a Medicare-enrolled provider, Safa has provided services to 4,994 Medicare beneficiaries, totaling 8,510 services with total Medicare billing of $628,380. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Vienna, VA
- Active Since 11/20/2006
- Last Updated 01/24/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952475048
Products in Payments
- TRULICITY (Drug) $369.38
- Ozempic (Drug) $306.65
- Wegovy (Drug) $299.52
- Repatha (Biological) $282.57
- MOUNJARO (Drug) $256.86
- Minimed 630G (Device) $232.62
- Synthroid (Drug) $187.98
- BAQSIMI (Drug) $181.00
- JARDIANCE (Drug) $163.50
- FibroScan (Device) $159.60
- Androgel (Drug) $127.23
- HUMULIN (Drug) $121.73
- TOUJEO (Biological) $116.91
- SUPERA (Device) $116.77
- SYNTHROID (Drug) $104.21
- GVOKE HYPOPEN (Drug) $92.72
- Omnipod (Device) $90.93
- t:slim X2 Insulin Pump with Control-IQ (Device) $83.84
- Tirosint (Drug) $65.35
- UNITHROID (Drug) $61.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.